Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection [PDF]
, 2016 Jeanette M. Tetrault +15 more
openalex +1 more source
A rational approach to opioid use disorder in primary care [PDF]
, 2017 Daniel G. Tobin
openalex +1 more source
Chronic pain among patients with opioid use disorder: Results from electronic health records data [PDF]
, 2017 Yih‐Ing Hser +5 more
openalex +1 more source
Treatment of Refractory Opioid Use Disorder [PDF]
Journal of General Internal Medicine, 2021 Mimi Yen Li +2 more
openaire +2 more sources
Integrated Pharmacy Research and Practice, 2019 Bryn Lindley,1 Nicholas Cox,2 Gerald Cochran31University of Utah, College of Pharmacy, Salt Lake City, UT, USA; 2University of Utah, College of Pharmacy, Department of Pharmacotherapy, Salt Lake City, UT, USA; 3University of Utah, School of Medicine ...
Lindley B, Cox N, Cochran G
doaj
Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder [PDF]
, 2017 Alexis K. Matusiewicz +2 more
openalex +1 more source
Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder [PDF]
, 2017 Michael D. Stein +6 more
openalex +1 more source
Expanding Treatment Opportunities for Hospitalized Patients with Opioid Use Disorders [PDF]
, 2017 Daniel Winetsky +2 more
openalex +1 more source
Experiences of three states implementing the Medicaid health home model to address opioid use disorder—Case studies in Maryland, Rhode Island, and Vermont [PDF]
, 2017 Lisa Clemans-Cope +5 more
openalex +1 more source
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome [PDF]
, 2017 Niraj R. Chavan +4 more
openalex +1 more source